The FTC Second Request signals heightened antitrust scrutiny and likely delays the merger close by several months. Monitor for any divestiture requirements or further regulatory pushback that could alter deal terms or probability of completion.
Price Chart
Executive Summary
Sanara MedTech disclosed that it and MiMedx each received a Second Request from the FTC on October 15, 2026, extending the HSR Act waiting period for their pending merger. The deal remains subject to regulatory clearance, and the companies are cooperating with the FTC. This introduces a material delay and uncertainty into the merger timeline.
Key Financial Metrics
Key Facts
- Sanara and MiMedx each received a Second Request from the FTC on October 15, 2026.
- The Second Request extends the HSR Act waiting period until 30 days after substantial compliance, unless extended or terminated earlier.
- The merger is structured as a reverse triangular merger with Sanara surviving as a wholly-owned subsidiary of MiMedx.
- The final prospectus has been mailed to Sanara stockholders.
Financial Impact
No financial figures disclosed; the Second Request introduces a material delay and potential regulatory risk to the merger.
Risk Factors
- Extended HSR review could push closing into 2027 or beyond.
- FTC may require divestitures or impose conditions that reduce deal value.
- If the merger fails, Sanara shares could reprice to standalone valuation.
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 425 Filing (Primary) | 0001213900-26-110056 |
| Document: 0001213900-26-110056-index-headers.html | 0001213900-26-110056 |
| Document: 0001213900-26-110056-index.html | 0001213900-26-110056 |
| Document: 0001213900-26-110056.txt | 0001213900-26-110056 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 16, 2026 11d ago | 425 | $33.16 $32.80 | ▲ +1.09% | ▲ +1.18% | $32.84 (+0.97%) |
Oct 16, 2026 11d ago | 8-K | $33.16 $32.80 | ▼ −1.09% | ▼ −1.18% | $32.84 (−0.97%) |
Jul 30, 2026 12w ago | 425 | $34.06 $34.09 | ▲ +0.09% | ▼ −3.53% | $32.84 (−3.58%) |
Jul 30, 2026 12w ago | 425 | $34.06 $34.09 | ▲ +0.09% | ▼ −3.53% | $32.84 (−3.58%) |
Jul 30, 2026 12w ago | 425 | $34.06 $34.09 | ▲ +0.09% | ▼ −3.53% | $32.84 (−3.58%) |
Jul 30, 2026 12w ago | 425 | $34.06 $34.09 | ▲ +0.09% | ▼ −3.53% | $32.84 (−3.58%) |
Jun 4, 2026 20w ago | 8-K | $22.44 $20.81 | ▼ −7.26% | ▼ −7.83% | $32.84 (+46.35%) |
May 11, 2026 24w ago | 8-K | $20.44 $21.89 | ▲ +7.09% | ▲ +7.02% | $32.84 (+60.67%) |
Apr 17, 2026 27w ago | DEFA14A | $20.62 $18.93 | ▼ −8.20% | ▼ −9.11% | $32.84 (+59.26%) |
Apr 17, 2026 27w ago | DEFA14A | $20.77 $19.22 | ▼ −7.46% | ▼ −8.02% | $32.84 (+58.11%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers